期刊文献+

布拉氏酵母菌治疗婴幼儿轮状病毒肠炎35例效果观察 被引量:4

下载PDF
导出
摘要 目的:探讨布拉氏酵母菌(亿活,Bloflor)治疗婴幼儿轮状病毒肠炎的效果。方法:轮状病毒肠炎患儿69例,年龄均≤3岁,随机分为治疗组35例,对照组34例,两组均给予蒙脱石及其他对症支持治疗,其中治疗组在治疗的同时加用亿活。对两组的显效率、总有效率进行统计分析。结果:治疗组显效率74.3%,总有效率97.1%;对照组显效率44.1%,总有效率79.4%(P<0.05)。结论:亿活能明显提高轮状病毒肠炎的治疗显效率及总有效率,较为安全。具有积极的临床意义。
作者 肖钦志
出处 《南通大学学报(医学版)》 2011年第5期372-373,共2页 Journal of Nantong University(Medical sciences)
  • 相关文献

参考文献10

  • 1胡亚美 江载芳.诸福棠实用儿科学[M] 7版[M].北京:人民卫生出版社,2002.698-705.
  • 2方鹤松 魏承毓 段恕诚 等.腹泻病疗效判断标准的补充建议.中国实用儿科杂志,1998,13(6):384-384.
  • 3Szajewska H, Sk6rka A, Dylag M. Meta-analysis: Saccha- romyces boulardii for treating acute diarrhoea in children[J]. Aliment Pharmaeol Ther, 2007, 25(3):257-264.
  • 4Htwe K, Yee KS, Tin M, et al. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study[J]. Am J Trop Med Hyg, 2008, 78(2):214-216.
  • 5高源,赵玉霞,梅红.布拉氏酵母菌预防小儿肺炎继发腹泻的临床研究[J].临床儿科杂志,2008,26(3):220-221. 被引量:47
  • 6Zanello G, Meurens F, Berri M, Salmon H. Saccharomyces boulardii effects on gastrointestinal diseases[J]. Curr Issues Mol Biol, 2009, 11(1):47-58.
  • 7Buts JP, Dekeyser N, Stilmant C, et al. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation[J]. Pediatr Res, 2006, 60(1):24-29.
  • 8Sougioultzis S, Simeonidis S, Bhaskar KR, et al. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression[J]. Biochem Biophys Res Commun, 2006, 343(1): 69-76.
  • 9Mumy KL, Chen X, Kelly CP, et al. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 294(3):G599-G609.
  • 10Ozkan TB, Sahin E, Erdemir G, et al. Effect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune response[J]. J Int Med Res, 2007, 35(2):201-212.

二级参考文献9

  • 1唐秋雨,林滨榕,吴斌,黄妙辉.小儿肺炎继发腹泻相关因素分析及微生态制剂的预防作用[J].中国实用儿科杂志,2005,20(12):732-734. 被引量:119
  • 2杨锡强,易著文.儿科学[M].6版.北京:人民卫生出版社,2003:308
  • 3Turck D,Bemet Je,Marx J,et al.Incidence and risk factors of oral antibiotic-associated diarrhea in an out-patient pediatric population[J].J Pediatr Gastroenterol Nutr,2003,37(1):22-26.
  • 4Elmer GW,Surawicz CM,McFarland LV.Biotherapeutie agents.A neglected modality for the treatment and prevention of selected intestinal and vaginal infections[J].JAMA,1996,275(11):870-876.
  • 5World Health Organization.Saccharomyces boulardii:a valuable adjunct in recurrent Clostridium difficile disease?[J].WHO Drug Information,1995,9(6):15-16.
  • 6Klein SM,Elmer GW,McFarland LV,et al.Recovery and elimination of biotherapeutic agent,Saccharomyces boulardii in healthy human volunteers[J].Pharm Res,1993,10(11):1615-1619.
  • 7Blehaut H,Massot J,Elmer GW,et al.Disposition kinetics of Saccharemyees boulardii in man and rat[J].Biopharm Drug Dispes,1989,10(4):353-364.
  • 8Nicod-Bertin L,Panouse-Perrin J.Proprietes activatrices de deux preparations de levures via-(a)-vis du systeme complement human[J].Rev Inst Pasteur Lyon,1985,18(8):345-365.
  • 9方鹤松,魏承毓.中国腹泻病诊断治疗方案[J].中国实用儿科杂志,1998,13(6):381-384. 被引量:2227

共引文献1043

同被引文献23

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部